
Valeo Pharma Receives Approval from Health Canada for the Transfer of Commercial Rights to Ametop™
AmetopTM commercialization to begin in July 2020 First of four Valeo products scheduled for launch this summer MONTREAL , July 13, 2020 – Valeo Pharma Inc. (VPH.CN) (“Valeo” or the “Company“), a Canadian specialty pharmaceutical company, announced today […]